sublingual tablet


Also found in: Dictionary, Thesaurus, Encyclopedia.
Related to sublingual tablet: buccal tablet

tablet

 [tab´let]
a solid dosage form containing a medicinal substance with or without a suitable diluent. Called also pill.
buccal tablet one which dissolves when it is held between the cheek and gum, permitting direct absorption of the active ingredient through the oral mucosa.
enteric-coated tablet one coated with material that delays release of the medication until after it leaves the stomach.
sublingual tablet one that dissolves when held beneath the tongue, permitting direct absorption of the active ingredient by the oral mucosa.

sub·lin·gual tab·'let

usually a small, flat tablet intended to be inserted beneath the tongue, where the active ingredient is absorbed directly through the oral mucosa; such a tablet (for example, nitroglyerine) dissolves very promptly.

sub·lin·gual tab·let

(sŭb-linggwăl tablĕt)
Usually a small, flat fast-dissolving tablet intended to be inserted beneath the tongue, where the active ingredient is absorbed directly through the oral mucosa.

sub·lin·gual tab·let

(sŭb-linggwăl tablĕt)
Usually a small, flat form of medicine intended to be inserted beneath tongue, where the active ingredient is absorbed directly through oral mucosa; such a tablet (e.g., nitroglyerine) dissolves very promptly.
References in periodicals archive ?
is an innovative, pre-programmed, non-invasive, handheld system that allows hospital patients with acute moderate to severe post-operative pain to self-dose with sufentanil sublingual tablets to manage their pain.
Adverse events commonly observed with the sublingualadministration of buprenorphine/naloxone sublingual tablets during clinical trials and post-marketing experience areheadache, nausea, vomiting, hyperhidrosis, constipation, signs and symptoms of withdrawal, insomnia, pain andperipheral edema.
Ethypharm's sublingual tablet achieves a rapid onset by incorporating an innovative, patented novel drug delivery technology which allows a rapid Fentanyl absorption and systemic exposure to the analgesic.
Stallergenes has been conducting a phase IIb/III clinical trial, with a sublingual tablet in adults suffering from moderate to severe persistent allergic rhinitis to house dust mites, including 509 patients, over seven countries, with a full year of treatment from January to December 2008.
It is based on Orexo's unique and patented sublingual tablet technology in which a rapidly dissolving tablet is placed under the tongue and the active substance is absorbed by the mucous membrane.
Orexo Pharmaceuticals has announced that a European Patent has been granted for one of their technology platforms, the sublingual tablet technology.
All patients enrolled in this trial will be prescribed nitroglycerin, either in a sublingual tablet form or a lingual spray, to relieve the pain associated with angina.
The company's late-stage pipeline includes ARX-04 (sufentanil sublingual tablet, 30mcg) for the treatment of moderate-to-severe acute pain in a medically supervised setting; and Zalviso(TM) (sufentanil sublingual tablet system) for the management of moderate-to-severe acute pain in adult patients in the hospital setting.
Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute pain, today provided a regulatory update on Zalviso(TM) (sufentanil sublingual tablet system) intended for the management of moderate-to-severe acute pain in adult patients in the hospital setting.
NASDAQ: DYGN; BSE: DYG) today announced that it has begun a multi-center pivotal Phase 3 trial with NicErase-SL, a non-nicotine sublingual tablet to be used as an aid to smoking cessation.
Ford has worked with AcelRx as a consultant from 2013 to the present and has been instrumental in the development of a commercial strategy for Zalviso(TM) (sufentanil sublingual tablet system), a drug-device combination product now approved in Europe for the management of acute moderate-to-severe post-operative pain in adult patients.
Zalviso is a system combining a drug and a device designed to deliver a sublingual tablet formulation of sufentanil 15 mcg via a proprietary, pre-programmed, non-invasive, patient-controlled analgesia (PCA) device.